Navigation Links
Femasys Launches FemCerv Endocervical Sampler, A Revolutionary Solution For Cervical Cancer Screening
Date:4/30/2013

ATLANTA, April 30, 2013 /PRNewswire/ -- Femasys Inc., a medical device developer of women's healthcare solutions, announced today the U.S. launch of the 510(k) cleared FemCerv™, an innovative endocervical curettage device.  FemCerv is designed to collect a complete, non-contaminated tissue sample with minimal patient discomfort. Endocervical curettage has the potential for the detection of high-grade lesions or invasive cancer that may not be detected by other methods.  Femasys plans to initially focus on the U.S., where approximately 3.5 million women each year undergo a follow-up screening for cervical cancer.   

(Logo:  http://photos.prnewswire.com/prnh/20110502/CL93858LOGO )

Commenting on the announcement, Kathy Lee-Sepsick , President & CEO of Femasys Inc., said, "FemCerv serves to improve cancer screening options for women and allow physicians to provide the best care for their patients.  As we continue to offer revolutionary new products into the women's healthcare market, Femasys is driven by the difference we are making in the lives that we touch."

Limited U.S. market release of FemCerv has been extremely positive.  Femasys will provide hands-on demonstrations of the FemCerv Endocervical Sampler at the upcoming American Congress of Obstetricians and Gynecologists' (ACOG) 61st Annual Clinical Meeting in New Orleans, Louisiana, from May 5-8 at booth number 801.

Along with the CE mark, this 510(k) cleared device allows Femasys to expand commercialization efforts worldwide.  The company is actively seeking strategic partners.

Additional product information can be found at www.femcerv.com

ABOUT FEMASYS INC. | www.femasys.com
Femasys, based in Atlanta, GA, is a privately held corporation committed to advancing women's healthcare worldwide with innovative medical devices developed to meet the various needs that may arise during a woman's life. 

Business Development Contact:
Steven Damon , 770.598.6446, sdamon@femasys.com

Media Contact:
Jerry Fink , 770.500.3910, jfink@femasys.com

 


'/>"/>
SOURCE Femasys Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Femasys to Present at the 24th Annual Piper Jaffray Healthcare Conference
2. Prometheus Launches New Adalimumab Drug And Antibody Levels Monitoring Test
3. UBM Medica US Launches Practice Management iPad App, Offering Efficient Business Solutions for Busy Physicians
4. NextDocs Launches QuickStart for Emerging Growth Companies
5. Neusoft Medical Launches New Products to Global Market at 2013 Spring CMEF
6. Healthcares First Direct Contracting Market Launches Today; Will Offer Mutually Beneficial Approach for Hospitals and Suppliers
7. Sanovas Launches Next Generation Surgical Imaging Technology
8. MR Solutions Launches Complete Range of Pre Clinical Helium Free MRI Scanners
9. CSOS Launches the Guangdong-Hong Kong "999" Emergency Assistance Membership Programme
10. AsthmaSense Cloud Launches With New Features To Better Monitor Asthma
11. Aribex Launches NOMAD Pro 2 in US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , 22. März 2017   VWR ... weltweit tätige Anbieter von Produkten und Dienstleistungen ... Erwerb von EPL Archives Inc. bekannt, eines ... Kunden im kompletten Zyklus regulierter Forschung, Entwicklung ... Proben, Speicherung von Dokumenten und Zusatzdienstleistungen zur ...
(Date:3/22/2017)... March 22, 2017 TapImmune, Inc. ... in the development of innovative peptide and gene-based ... disease, today announced that it will participate in ... Dr. Glynn Wilson , Chairman and CEO ... company,s business, clinical pipeline and partnering opportunities for ...
(Date:3/22/2017)... March 22, 2017 A new independent ... is the proven ultraviolet-C (UV-C) disinfection solution of ... (HAIs). Published in the March ... Control , the peer-reviewed study of UV-C disinfection ... Vancouver General Hospital and Rochester General Hospital. According ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... 23, 2017 , ... “Beyond and Back”: a true-life testimony of tragedy and ... published author Bonetta Rose, a wife, mother and grandmother committed to sharing her many ... Publishing, Bonetta Rose‘s new book presents actual events in the life of her family, ...
(Date:3/23/2017)... , ... March 23, 2017 , ... “The Trainer”: ... of published author, Scotty, a fiction writer with an active imagination and an enthusiasm ... new book follows the tale of Wild Bill Hart, who sat looking at the ...
(Date:3/22/2017)... ... March 23, 2017 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had won the ... place at the Suntec Singapore International Exhibition & Convention Centre, Singapore. The award ...
(Date:3/22/2017)... ... March 22, 2017 , ... Soriant recognizes that ... bypasses that. Healthcare facilities across the country are always forced to focus ... and hospitals, across the country, an efficient and quick way to estimate savings ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Rett Syndrome Research ... neurological disorder that afflicts 350,000 individuals worldwide. Rett Syndrome is caused by ... exclusively strikes females. Following a normal infancy, Rett Syndrome takes effect in ...
Breaking Medicine News(10 mins):